نتایج جستجو برای: cd133 umbilical cord blood derived

تعداد نتایج: 1206005  

2012
Hong Hoe Koo Hyo Seop Ahn

Since the first umbilical cord blood transplantation (CBT) in 1998, cord blood (CB) has now become one of the most commonly used sources of hematopoietic stem cells for transplantation. CBT has advantages of easy procurement, no risk to donor, low risk of transmitting infections, immediate availability and immune tolerance allowing successful transplantation despite human leukocyte antigen disp...

Journal: :Clinical advances in hematology & oncology : H&O 2010
Qaiser Bashir Simon N Robinson Marcos J de Lima Simrit Parmar Elizabeth Shpall

Umbilical cord blood transplantation (CBT) has been widely used as an alternative source of hematopoietic cell support for stem cell transplant patients. CBT offers several advantages over traditional stem cell sources, such as immediate availability, absence of risk for donors, lower risk of acute graft-versus-host disease, and a less stringent requirement for human leukocyte antigen matching....

Journal: :Cancer treatment and research 1995
J E Wagner

Interest in umbilical cord blood as an alternative source of hematopoietic stem cells is growing rapidly. Umbilical cord blood offers the clinician a source of hematopoietic stem cells that are readily available and rarely contaminated by latent viruses. Moreover, the collection of umbilical cord blood poses no risk to the donor; there is no need for general anesthesia or blood replacement, and...

2004
Xiao Wu Elena Rabkin-Aikawa Kristine J. Guleserian Tjorvi E. Perry Yutaka Masuda Fraser W. H. Sutherland Frederick J. Schoen John E. Mayer Joyce Bischoff

Wu, Xiao, Elena Rabkin-Aikawa, Kristine J. Guleserian, Tjorvi E. Perry, Yutaka Masuda, Fraser W. H. Sutherland, Frederick J. Schoen, John E. Mayer, Jr., and Joyce Bischoff. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 287: H480–H487, 2004; 10.1152/ajpheart.01232. 2003.—Tissue engineering may...

2014
Kyung Chul Yoon

Among blood preparations, serum has been topically used in the management of various ocular diseases in ophthalmology. Like peripheral blood serum, umbilical cord blood serum contains a high concentration of essential tear components, growth factors, neurotrophic factors, vitamin A, fibronectin, prealbumin, and oil. Umbilical cord serum can provide basic nutrients for epithelial renewal and can...

2014
Jie Yan Yueran Zhu Huidan Liao Lina Su Yadong Guo Jifeng Cai

We report a rare case of an umbilical cord hemangioma. The umbilical cord consisted of Capillaries and cavernous blood vessels and the hemangioma stressed umbilical arteries and vein. At 40 weeks of gestation, it resulted in intrauterine death of the fetus. Microscopically, there were lots of vessels with various thicknesses in the umbilical cord. Autopsy shows evidences of smothering. These fi...

Journal: :Haematologica 2009
Maria Antonietta Avanzini Maria Ester Bernardo Angela Maria Cometa Cesare Perotti Nadia Zaffaroni Francesca Novara Livia Visai Antonia Moretta Claudia Del Fante Raffaella Villa Lynne M Ball Willem E Fibbe Rita Maccario Franco Locatelli

BACKGROUND Mesenchymal stromal cells are employed in various different clinical settings in order to modulate immune response. However, relatively little is known about the mechanisms responsible for their immunomodulatory effects, which could be influenced by both the cell source and culture conditions. DESIGN AND METHODS We tested the ability of a 5% platelet lysate-supplemented medium to s...

2016
Sang-Jin Park Hyun-Jung Kim Woojin Kim Ok-Sun Kim Sunyeong Lee Su-Yeon Han Eun Ju Jeong Hyun-shin Park Hea-Won Kim Kyoung-Sik Moon

Mesenchymal stem cells (MSCs) have been identified in multiple types of tissue and exhibit characteristic self-renewal and multi-lineage differentiation abilities. However, the possibility of oncogenic transformation after transplantation is concerning. In this study, we investigated the tumorigenic potential of umbilical cord blood-derived MSCs (hUCB-MSCs) relative to MRC-5 and HeLa cells (neg...

2014
Lukas Wisgrill Simone Schüller Markus Bammer Angelika Berger Arnold Pollak Teja Falk Radke Gesine Kögler Andreas Spittler Hanns Helmer Peter Husslein Ludwig Gortner

BACKGROUND In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs from early preterm neonates under different perinatal conditions. Therefore, we investigated the co...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید